chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I took a vitamin B12 injection (as I normally do once a week) the day after getting my vaccine booster shot, however the day after doing so I started to develop large blisters on my stomach (near the B12 injection site) that then spread and continued to grow, until they utimately popped and became infected, cause sever discomfort and fever for approx 2 weeks (infection is gone but wounds are still present and healing).  I also had a very tight chest and was short on breath for about 2 weeks.  I have n very had this reaction to B12 before and have since take a B12 shot from the same lot with no reaction, the only thing different when I had the bad reaction was that I was recent covid booster shot I took.
RIGHT ARM IS SWOLLEN FROM SHOULDER TO ELBOW, RED FEVERISH ON SITE OF INJECTION, HEAVY FOR LIFTING, CHILD HAD FEVER OF 101, ITCHING ON SITE OF INJECTION. PARENT PLACED COLD PAD ON THE INJECTION SITE THE NIGHT OF VACCINATION.
Past out and appeared to may have had mild seizure with eyes rolled back and perspiration. Patient was unconscious for approximately 30sec-1min.
Fever was up to 102.4; Chills; Body ache; This is a spontaneous report from a contactable consumer (patient herself). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 27Dec2020, the patient experienced fever was up to 102.4, chills, and body ache. Therapeutic measures were taken as a result of the events that included ibuprofen (Motrin). Clinical outcome of the events was unknown.  Information on the lot/batch number has been requested.
Symptom: Joint pain, multiple joints Comment: migratory joint pain; denies muscle pain but describes "bone pain". Pt describes nausea and vomiting and diarrhea as starting around Spring 2003. No triggers identified such as diet changes or stress, but always associated with cycles of joint pain. (Does not know "what end to put on toiler...feels like I'm going to throw up and have diarrhea".) No significant weight loss. His Internist recommended an evaluation by a Gastroenterologist, but service member has not followed through at this time. No abdominal pain, constipation, cramping or bloating. No blood in stools. N history of reflex disease, ulcers, liver disease and gall bladder disease. Reports onset of fatigue in 2002. Describes as feeling drained and having no energy to perform usual activities-"sometimes dragging when I get up" and some days fatigue hits him in the middle of the day. Typically has about 10-15 "good days" per month where he can carry out duties and activities of daily living without problems. On "bay days" rates his energy level as being 20% of his baseline prior to 2002. Longest period over past 12 months where he did not feel fatigued was 3 weeks. No particular pattern of fatigue noted. Denies feeling weak or sleepy. Fatigue does not seem to be affected by alcohol or any medications that he has taken. Fatigue does not seem to be triggered or exacerbated by activity but generally he will no even attempt activities on his "bad days". On a good day, he can carry out activities without noting a prolonged recovery; during a recent period of fatigue he hired his brothers to clean his yard. Denies associated headaches, visual changes, memory changes or difficulty concentrating, but as previously noted , experiences sore throats and migratory arthralgias. 6/2002-Acute earache prior to onset of migratory joint pains. 6/2002-pharyngitis, acute; experiences sore throats prior to onset of migratory joint pains. 2002-malaise and fatigue; chronic fatigue associated with migratory arthralgias. 2002-pain in joints, migratory joint and "bone" pain.
Sore arm began around 4:00pm, around 7:00pm I was developing body aches and a headache. By 9:00pm I had fever and chills and body aches all over.  Fever and chills seemed to subside by 4:00am, headaches and body aches are still present but not as severe.
Mom feel pt having rxn referred to pvt MD 28JAN92 approx 430PM t99, faint rash back of head & few on cheek; no other sx; no abnormality @ inject sites; DPH given;
the patient died after getting the Pfizer BioNtech Covid vaccine; This is a spontaneous report from a Pfizer Sponsored Program. A non-contactable consumer reporting same event under the same suspect product for 6 patients. This is one of 6 reports.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and the patient's concomitant medications were not reported.  The patient died on an unspecified date.  It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101275697 same reporter, same vaccine, same adverse event, different patient;US-PFIZER INC-202101276043 same reporter, same vaccine, same adverse event, different patient; Reported Cause(s) of Death: unknown cause of death
Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Tachycardia-Mild, Systemic: Weakness-Medium
Patient was supposed to be given second dose of SHINGRIX and was give Zoster by mistake. Also Zoster Vaccine had expired 4 months prior to administration. Patient did not report any adverse effects.
I felt extremely dizzy and my world spun.  By bed time, i was shaking very violently and had a fever. I cried myself to sleep due to the pain experienced with the shaking. I woke up with high fever and extreme body pain. All joints and body hurt so much. I slept most of the day in pain. Fevers throughout the day.  I saw improvement by 5pm or so but will never take this vaccine again. I have never experienced adverse effects after a vaccine. My husband thought I would have to go to the hospital.
Post vax, the pt developed rash and redness, started itching on 12/6/00. Applied ointment on 12/7/00.
patient had the first dose of the Pfizer COVID-19 vaccine on 30Jan2021 and tested positive on 12Feb2021; patient had the first dose of the Pfizer COVID-19 vaccine on 30Jan2021 and tested positive on 12Feb2021; This is a spontaneous report from a contactable consumer via Medical information team. This consumer reported similar events for 2 patients. This is 2nd of 2 reports. A female patient (wife) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 30Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had the first dose of the Pfizer COVID-19 vaccine on 30Jan2021 and tested positive on 12Feb2021. The caller wanted to know whether they should repeat the dose or should they wait. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021166986 same reporter, suspect, events, different patient
Initial report was received from a health care professional on 22 October 2010. A 35 year-old male patient, had received on 19 October 2010 a subcutaneous injection of ADACEL (lot number and site of administration not reported) and a Influenza vaccine (manufacturer, lot number, route and site of administration not reported). On 20 October the patient experienced a two inch by two inch area of redness, warmth and swelling. He also complained of itching and pain. Th patient's past medical history, concomitant medications and treatments provided were not reported. No further information was available at the time of the report. The patient's outcome was not recovered. The reporter for this case is the same as for 2010-06137. Documents held by sender: none.
It just started like little tiny bumps on my left breast. There were larger lumps under the skin about the size of the tip of your finger. It itched till I was almost raw. It never went away. I started to use over-the-counter cortisone. I decided to go to the doctor and the medication they prescribed was, clobetasol propionate cream USP 0.05%, and so far it hasn't worked and I'm supposed to have a follow up appointment to see what they are going to try next.
Patient had a seizure like event for 20 seconds with low blood pressure as well, normal glucose levels.
Tenderness and slight swelling in my left neck and left armpit; Tenderness and slight swelling in my left neck and left armpit; This is a spontaneous report from a contactable nurse. A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EK5730, first dose via an unspecified route of administration in left arm on 17Dec2020 20:30 at single dose for COVID-19 immunization. Medical history included COVID-19 prior to vaccination and penicillin allergy from an unknown date and unknown if ongoing. On 19Dec2020, the patient stated, "tenderness and slight swelling in my left neck and left armpit on day 2 after vaccine. The patient had no other vaccine in four weeks. The patient had taken other unspecified medications in two weeks. No treatment was given to patient for the events. The patient had COVID prior vaccination to vaccination and not had COVID test post vaccination. The events were reported as non serious as it did not result in death, not life threatening, did not cause prolonged hospitalization, not disabling or incapacitating and no congenital anomaly or birth defect. The outcome of the events was not recovered.
Information has been received from a licensed practical nurse concerning 7 female patients who in approximately August 2001 were vaccinated with doses of pneumococcal vaccine 23 polyvalent (lot # unknown). There were no concomitant vaccinations, but it was unknown if there were concomitant drug therapies. Subsequently, the patients presented to the physician's office with severe arm pain in the entire arm, injection site edema 3-6 inches wide and injection site induration 3-6 inches wide. IT was reported that the swelling spread into the underlying tissue 3 inches in all directions from the injection site. It was noted that the patients were afebrile. The patients were treated with cold packs and acetaminophen (TYLENOL). It was reported that the patients recovered. Follow up information indicated that the reporter felt that the patients' severe arm pain in the entire arm, injection site induration 3-6 inches wide and injection site swelling/edema 3-6 inches wide were not related to the therapy with pneumococcal vaccine 23 polyvalent, but rather due to improper technique administering the shot. No further information is available.
pt reports red, swollen, itchy upper lt arm near inj site;by 2 days later states entire upper lt arm to just below the lt elbow was red, swollen & very itchy;vomiting & h/a;
7/16/02 vomiting q pm for 3 days (7/16/02-7/19/02) (? fever feeling warm); loose stools. 7/22/02 body rash/shaking/poor appetite/morbilliform rash. 9/4/02 low grade fever and vomiting for three days. Recurrence of morbilliform rash today. 7/02 episode-yes.
felt like crap for 2 days; Initial information received on 12-Dec-2020 and additional information received on 22-Dec-2020 regarding an unsolicited valid non-serious social media case received from a consumer (patient).  This case is linked to case 2020SA300039 and 2020SA300039.  This case involves a patient of unknown demographics who felt like crap for 2 days (feeling abnormal), when received Influenza Vaccine.  The patient's medical history, medical treatments, vaccinations, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer (batch number and expiration date unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date (latency unknown) after the administration of suspect the patient felt like crap for 2 days (feeling abnormal).  It was not reported if the patient received a corrective treatment.  The outcome of event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
feeling unwell; fever; chills; muscle pain; bottom of the feet were itchy; headache; rash on the chest; This is a spontaneous report from a contactable consumer (patient). A 59-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 15Mar2021 as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization and experienced mild reactions from the 1st dose. On 15Mar2021, the patient experienced reactions from the vaccine at night, feeling unwell, fever, chills, muscle pain, bottom of the feet were itchy, headache, and rash on the chest. The patient underwent lab test and procedures which included body temperature: fever on 15Mar2021. Therapeutic measures were taken as a result of the event rash on the chest. Nurse advised the patient to put hydrocortisone cream for the rash. The patient queried whether there would be a need for 3rd dose of the PFIZER-BIONTECH COVID-19 VACCINE. The clinical outcome for the events was unknown.  Information about lot/batch number has been requested.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Initial unsolicited report received from the literature on 18 March 2017. This case was linked to 2017SA047674 (same literature). The following is verbatim from the article: Background. Case reports have suggested that vaccines may trigger transverse myelitis (TM) or acute disseminated encephalomyelitis (ADEM), but the evidence for a causal association is inconclusive. We analyzed the association of immunization and subsequent development of TM or ADEM. Methods. We identified all cases of TM and ADEM in the Vaccine Safety Datalink population. Using a case-centered method, we compared vaccination of each case to vaccination of all matched persons in the study population, who received the same type of vaccine, with respect to whether or not their vaccination occurred during a predetermined exposure interval. We calculated a risk difference (excess risk) of TM and ADEM for each vaccine. Results. Following nearly 64 million vaccine doses, only 7 cases of TM and 8 cases of ADEM were vaccinated during the primary exposure window 5-28 days prior to onset. For TM, there was no statistically significant increased risk of immunization. For ADEM, there was no statistically significant increased risk following any vaccine except for Tdap (adolescent and adult tetanus, reduced diphtheria, acellular pertussis) vaccine. Based on 2 exposed cases, the odds ratio for Tdap exposure 5-28 days prior to ADEM onset was 15.8 (95% confidence interval [CI], 1.2-471.6; P = .04), and the estimated excess risk was 0.385 (95% CI, .04 to 1.16) cases per million doses. Conclusions. We found no association between TM and prior immunization. There was a possible association of ADEM with Tdap vaccine, but the excess risk is not likely to be more than 1.16 cases of ADEM per million vaccines administered. This case involves a patient (age and gender not reported) who was vaccinated with a dose of DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (Tdap) (batch number, expiration date, dose, site and route of administration were not reported) on an unknown date. Patient's medical history and concomitant medications were not reported. On an unknown date following the vaccination, the patient developed acute disseminated encephalomyelitis. Relevant laboratory test results and corrective treatment were not reported. Outcome of the event was not reported. Upon internal review the case was considered as serious because of important medical event acute disseminated encephalomyelitis. The reporter assessed the causal relationship of event with Tdap as possible. Documents held by sender: none. Sender's Comments: Patient was diagnosed with Acute Disseminated Encephalomyelitis (ADEM), following TDAP VACCINE. Time to onset is compatible but additional information regarding patient detail medical history, infectious history which could trigger immune system, family history of any immune disorder, past vaccination history and its tolerance are needed to further assess the case. Based on available information the role of vaccine cannot be assessed.
Employee here with COVID vaccination reaction received vaccination in left upper arm deltoid area. Noticed 01/13/21 that the area was, red, swollen, warm to the touch, itching. Area in clinic measures 9 X 5.5cm and outlined in ink. Explained conservative measures including cool compresses, and if approved by PCP OTC IUB, OTC antihistamines. Explained signs of cellulitis and if the area worsens to seek further care with either PCP or urgent care. Employee verbalizes understanding and agrees with plan.
Pt had a temperature of 106 F. Treated with Motrin. She vomited 3 times. Was seen in ER. She appeared recovered the next day.
No adverse event; Dose 3 (1st monovalent booster) was 0.3 ml; This spontaneous case was reported by an other health care professional and describes the occurrence of OVERDOSE (Dose 3 (1st monovalent booster) was 0.3 ml) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 32030BD) for COVID-19 prophylaxis.     It was unknown if patient was ever been diagnosed with/ tested positive for COVID-19. It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before or chronic or long-standing health conditions or patient was taking any prescriptions, over-the-counter medications, dietary supplements, or herbal remedies at time of vaccination and/or at the time of the adverse event.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .3 milliliter. On 01-Dec-2021 at 9:54 AM, the patient experienced OVERDOSE (Dose 3 (1st monovalent booster) was 0.3 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, OVERDOSE (Dose 3 (1st monovalent booster) was 0.3 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for OVERDOSE (Dose 3 (1st monovalent booster) was 0.3 ml).    Patient administered the Dose 3 of the vaccine at 09:54 am on 01-Dec-2021.   No concomitant medication reported. No treatment medication reported.   This case was linked to MOD-2023-704660 (Patient Link).
Patient received his second AstraZeneca  vaccine on 6/9/21 and came for Pfizer booster vaccine. Doctor called & approve to give vaccine. Vaccine was given earlier (~1 month) to the patient.  Patient did not c/o any side effects during observation period.
got the vaccination and now I've had them  / suspected vaccination failure; had them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had the shingles, one time got the vaccination and now patient had shingles live or six times This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
Patient came in and stated that on 9/17/15 her arm was swollen and painful. She states that she could not lift her arm all the way up and had a small bump on her arm.
Large red rash around injection site. Heating pad and ice used to help but no effect on rash.
This spontaneous case was reported by a consumer and describes the occurrence of RASH (started getting rash), URTICARIA (Hives upper part of the arm) and PRURITUS (itchy) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced RASH (started getting rash), URTICARIA (Hives upper part of the arm) and PRURITUS (itchy). At the time of the report, RASH (started getting rash) had not resolved and URTICARIA (Hives upper part of the arm) and PRURITUS (itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided. Treatment information was not provided.